(Q34231585)

31 July 2017

The neuropathology, pathophysiology and genetics of multiple system atrophy (English)

1 reference

31 July 2017

1 reference

4

A J Lees

1 reference

31 July 2017

7

J L Holton

1 reference

31 July 2017

Z Ahmed

1

1 reference

31 July 2017

Y T Asi

2

1 reference

31 July 2017

A Sailer

3

1 reference

31 July 2017

H Houlden

5

1 reference

31 July 2017

T Revesz

6

1 reference

31 July 2017

1 February 2012

1 reference

Neuropathology and Applied Neurobiology

31 July 2017

1 reference

31 July 2017

38

1 reference

31 July 2017

1

1 reference

31 July 2017

4-24

1 reference

Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy

31 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiple system atrophy: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Consensus statement on the diagnosis of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Second consensus statement on the diagnosis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Mapping the human brain: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Recent developments in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiple system atrophy: a review of 203 pathologically proven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Myelin degeneration in multiple system atrophy detected by unique antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Microglial activation parallels system degeneration in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Cellular pathology in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

A novel grading scale for striatonigral degeneration (multiple system atrophy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

The phenotype spectrum of Japanese multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

"Minimal change" multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy-cerebellar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiple system atrophy with remarkable frontal lobe atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Argyrophilic grain disease is a sporadic 4-repeat tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

TDP-43 pathology occurs infrequently in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

A novel brain-specific 25 kDa protein (p25) is phosphorylated by a Ser/Thr-Pro kinase (TPK II) from tau protein kinase fractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

An unstructured protein with destructive potential: TPPP/p25 in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

The expression of tubulin polymerization promoting protein TPPP/p25alpha is developmentally regulated in cultured rat brain oligodendrocytes and affected by proteolytic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

P25alpha/Tubulin polymerization promoting protein expression by myelinating oligodendrocytes of the developing rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Molecular and cellular biology of synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Widespread alterations of alpha-synuclein in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

In vitro models of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Glial cell death induced by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Animal models of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Microglia and neuroinflammation: a pathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Mutant alpha-synuclein overexpression mediates early proinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Genetic players in multiple system atrophy: unfolding the nature of the beast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Environmental— occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Definite multiple system atrophy in a German family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiplex families with multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Spinocerebellar ataxia type 2 with glial cell cytoplasmic inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

SNCA variants are associated with increased risk for multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Reply to: SNCA variants are associated with increased risk of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

SNCA variants and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Tau-positive glial cytoplasmic granules in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Mutational analysis of parkin and PINK1 in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Multiple system atrophy: a primary oligodendrogliopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Familial aggregation in atypical Parkinson’s disease: a case control study in multiple system atrophy and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

Microglial activation mediates neurodegeneration related to oligodendroglial α-synucleinopathy: Implications for multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01234.X

10.1111/J.1365-2990.2011.01234.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference